Production (Stage)
Maze Therapeutics, Inc.
MAZE
$12.93
-$0.41-3.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 909.58% | 574.98% | -- | -70.82% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -1.88% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -- | 491.24% | -- | -- | |
|
|
|||||
| Total Current Assets | -- | 491.24% | -- | -- | |
| Net Property, Plant & Equipment | -- | -14.48% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 271.49% | -- | -- | |
| Total Assets | -- | 236.40% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -- | -3.96% | -- | -- | |
| Total Accrued Expenses | -- | 43.78% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | 3.19% | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | -- | 26.70% | -- | -- | |
|
|
|||||
| Total Current Liabilities | -- | 26.70% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -12.21% | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -- | -28.99% | -- | -- | |
|
|
|||||
| Common Stock & APIC | -- | 116.34% | -- | -- | |
| Retained Earnings | -- | 9.42% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 178.12% | 16.76% | -- | -32.35% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | 32.35% | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | 32.35% | -- | 0.00% | |
|
|
|||||
| Total Common Equity | 178.12% | 16.76% | -- | -32.35% | |
| Total Preferred Equity | -- | 32.35% | -- | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 2,804.99% | 1,858.46% | -- | -90.09% | |
|
|
|||||